APA

Kurtz D. M., Tschetter L. K., Allred J. B., Geyer S. M., Kurtin P. J., Putnam W. D., Rowland K. M., Wiesenfeld M., Soori G. S., Tenglin R. C., Bernath A. M. & Witzig T. E. (20070926). Subcutaneous interleukin-4 (IL-4) for relapsed and resistant non-Hodgkin lymphoma: a phase II trial in the North Central Cancer Treatment Group, NCCTG 91-78-51. : Leukemia & lymphoma.

Chicago

Kurtz David M, Tschetter Loren K, Allred Jacob B, Geyer Susan M, Kurtin Paul J, Putnam Wesley D, Rowland Kendrith M, Wiesenfeld Martin, Soori Gamini S, Tenglin Richard C, Bernath Albert M and Witzig Thomas E. 20070926. Subcutaneous interleukin-4 (IL-4) for relapsed and resistant non-Hodgkin lymphoma: a phase II trial in the North Central Cancer Treatment Group, NCCTG 91-78-51. : Leukemia & lymphoma.

Harvard

Kurtz D. M., Tschetter L. K., Allred J. B., Geyer S. M., Kurtin P. J., Putnam W. D., Rowland K. M., Wiesenfeld M., Soori G. S., Tenglin R. C., Bernath A. M. and Witzig T. E. (20070926). Subcutaneous interleukin-4 (IL-4) for relapsed and resistant non-Hodgkin lymphoma: a phase II trial in the North Central Cancer Treatment Group, NCCTG 91-78-51. : Leukemia & lymphoma.

MLA

Kurtz David M, Tschetter Loren K, Allred Jacob B, Geyer Susan M, Kurtin Paul J, Putnam Wesley D, Rowland Kendrith M, Wiesenfeld Martin, Soori Gamini S, Tenglin Richard C, Bernath Albert M and Witzig Thomas E. Subcutaneous interleukin-4 (IL-4) for relapsed and resistant non-Hodgkin lymphoma: a phase II trial in the North Central Cancer Treatment Group, NCCTG 91-78-51. : Leukemia & lymphoma. 20070926.